Roughly 10% of people worldwide experience symptoms associated with Irritable Bowel Syndrome (IBS) and due to the nature of this disorder, achieving any degree of relief is extremely challenging for patients.  However, a significant milestone has been achieved during a clinical trial conducted by Enbiosis, a biotechnology company that specializes in developing personalized nutrition plans […]